I ndIvIduals with Majewski osteodysplastic primordial dwarfism Type II (MOPD II) (Online Mendelian Inheritance in Man #210720) are among the smallest human beings at maturity. Their pleasant outgoing personality, high-pitched nasal voice, and distinctive facial features make them quite recognizable. Their life expectancy is decreased to 20s or 30s. In a natural-history study from Hall et al.
which organizes the mitotic spindle. The loss of PCNT impedes cell division, decreases cellularity of the embryo, and leads to severe growth restriction. 9 Features include proportionate intrauterine growth retardation, poor postnatal growth, extremely small stature (adult height < 100 cm), severe microcephaly, skeletal dysplasia, characteristic facial features, and normal or near-normal intelligence. 7 Previous studies 1, 3 have shown that 25%-50% of patients with MOPD II have intracranial vascular anomalies, which include moyamoya disease (MMD) and multiple intracranial aneurysms, both of which can be a major cause of stroke or early death. 3 Early diagnosis is critical for reducing morbidity and postponing death in these patients, and a screening program using MR angiography has been implemented. 1 However, because of the patients' extremely small size, diminutive arteries, and narrow anatomical corridors, surgical management of these intracranial anomalies is quite challenging, and few successful surgical cases have been reported in the literature. Here, we present our institutional results for this patient group.
Methods
A prospectively collected institutional surgical database of children with MOPD II and intracranial vascular anomalies in whom surgery was performed at Stanford University Medical Center between 2005 and 2012 by the senior author (G.K.S.) was analyzed retrospectively. Patients' clinical notes, imaging findings, and operative video recordings were reviewed. Long-term outcome data were obtained from the Potentials Foundation Primordial Registry, an approved prospective registry of patients with MOPD II located at Nemours/Alfred I. duPont Hospital for Children.
results
Ten patients with MOPD II underwent surgery between 2005 and 2012; 5 patients had MMD, 2 had intracranial aneurysms, and 3 had both MMD and aneurysms. The patients presented with transient ischemic attack (TIA) (n = 2), ischemic stroke (n = 2), intraparenchymal hemorrhage from MMD (n = 1), and aneurysmal subarachnoid hemorrhage (SAH) (n = 1), and 4 were diagnosed on screening ( Table 1) .
The mean age of the 8 patients with MMD, all of whom underwent extracranial-intracranial revascularization (14 indirect, 1 direct), was 9 years (range 1-17 years). The diameter of the distal superficial temporal artery (STA) was 0.3-1.0 mm (mean 0.6 mm). There were no postoperative complications after bypass surgery.
The mean age of the 5 patients with aneurysms was 15.5 years (range 9-18 years). Two patients experienced postoperative complications, 1 with transient left-sided weakness after aneurysm clipping (no infarct seen on postoperative diffusion-weighted MRI of the brain) and 1 with femoral thrombosis (after a diagnostic angiogram), which required subsequent surgical repair. Two patients also underwent endovascular coiling of intracranial aneurysms.
During a mean follow-up of 5.9 years (range 3-10 years), 3 patients died (1 as a result of SAH caused by a new untreated aneurysm, 1 as a result of myocardial infarction 6 years after surgery, and 1 as a result of respiratory failure 4 years after surgery), and 1 patient had occasional mild TIAs. All surviving patients recovered to their neurological baseline.
illustrative Cases
Case 1 A 10-month-old girl (initial birth weight 1.0 kg, birth length 35 cm) with MOPD II and craniosynostosis presented with a new-onset seizure. Brain MRI showed a left posterior parietal infarct. An angiogram revealed bilateral high-grade stenoses of the middle cerebral arteries (MCAs) and anterior cerebral arteries, with a network of collateral blood vessels consistent with bilateral MMD (Fig. 1A-D) . A SPECT scan revealed decreased perfusion in the bilateral parietal occipital regions with no augmentation after acetazolamide challenge, indicating impaired hemodynamic reserve. She underwent uneventful bilateral indirect encephaloduroarteriosynangiosis bypass procedures staged 1 week apart and was discharged after each surgery on Postoperative Day 3. Postoperative angiography at 18 months revealed patent bilateral bypass grafts supplying the bilateral MCA territories with progressive stenosis of the bilateral internal carotid arteries (ICAs) ( Fig. 1E-H) . At 2.5 years of age, she also underwent bilateral frontoorbital advancement for craniosynostosis correction. Six years after surgery, she remains neurologically normal.
Case 8
A 17-year-old boy with MOPD II (weight 13.2 kg, height 100 cm) presented with sudden-onset severe headache, nausea, and vomiting consistent with SAH. He then was diagnosed with a ruptured left posterior inferior cerebellar artery (PICA) aneurysm ( Fig. 2A ), bilateral MMD with supraclinoid ICA stenosis, and extensive collateral vessels (Fig. 3A-D) . Brain MRI showed no evidence of infarct, and SPECT revealed a perfusion defect in the right parietal cortex. Over a 3-week period he underwent clipping of the left PICA aneurysm, a right direct extracranial-to-intracranial bypass (using a 0.9-mm STA branch to a 0.9-mm M 4 branch of the MCA [Fig. 4 ]; indocyanine green videoangiography confirmed graft patency), and an indirect left extracranial-to-intracranial bypass. He had an excellent postoperative recovery; angiography 6 months after surgery confirmed complete obliteration of the PICA aneurysm (Fig. 2B ) and patent bilateral bypass grafts supplying the majority of the cortical hemispheres ( Fig. 3E and F). After 7 years of follow-up, he remained neuro- logically normal; angiography revealed an asymptomatic 3-mm left P 1 aneurysm that had not changed over the 7 years (Fig. 2C) .
Case 10
An 18-year-old boy with MOPD II (weight 12.3 kg, height 83.8 cm) and multiple health problems since birth, including gastroesophageal reflux disease, developmental delay, scoliosis (for which he underwent corrective surgery), recurrent urinary tract infections, and chronic renal insufficiency, was found to have 3 intracranial aneurysms during the screening process. He underwent clippings of a 6-mm MCA aneurysm, a 4-mm anterior communicating artery (ACoA) aneurysm, and a 10-mm partially throm- bosed pericallosal aneurysm (Fig. 5, left) . He developed some transient postoperative left-sided weakness, most likely related to retraction injury, which subsequently improved. Magnetic resonance imaging revealed no evidence of postoperative cerebral diffusion-weighted infarcts. Postoperative angiography confirmed complete obliteration of the intracranial aneurysms (Fig. 5 right) . Subsequent follow-up angiography 2 years later revealed a new 3-mm vertebrobasilar (VB) aneurysm (Fig. 6B) , which was treated with endovascular coil embolization; complete occlusion was achieved (Fig. 6C) . After 5 years of follow-up, he was well and had no neurological problems.
Discussion
Majewski osteodysplastic primordial dwarfism Type II (Online Mendelian Inheritance in Man #210720) is a distinctive diagnostic entity within the microcephalic primordial dwarfism group and one of the most common conditions encountered. 8, 13 Aside from the classic features of severe prenatal and postnatal growth failure, individuals with MOPD II have a characteristic skeletal dysplasia, 3, 12 abnormal dentition, 6 insulin resistance 4 and an increased risk for cerebrovascular disease 1, 2, 10 The disorder is caused by mutations in the PCNT gene and is inherited in an autosomal recessive manner. Moyamoya disease and multiple intracranial aneurysms represent independent sources of morbidity and death in up to 50% of patients with MOPD II. Some of our patients also exhibited coexistence of the 2 intracranial vascular pathologies.
In our small series, MMD affected the younger patients, whereas older patients developed intracranial aneurysms (which ruptured in 2 patients). Because of the progressive nature of new intracranial vascular anomalies in patients with MOPD II, we recommend long-term vascular imaging surveillance for the development of new vascular anomalies or progression of existing ones. We advocate MR angiography (preferred to reduce the long-term radiation risk) or CT angiography at diagnosis and then annually for life; cerebral angiograms should be obtained when clinically indicated to study the cerebral vasculature in greater detail.
As found in our case series, 1 patient developed a new aneurysm 2 years after initial imaging. We believed that it was important to treat this aneurysm early even though it was small (less than 7 mm in diameter). According to International Study of Unruptured Intracranial Aneurysms (ISUIA) data, 11 aneurysms in the posterior circulation less than 7 mm in diameter have only a 2.5% 5-year cumulative rupture rate; however, this finding would not necessarily apply to our cohort of patients with MOPD II, because such patients were not included in the ISUIA study. Therefore, we elected to treat the aneurysm aggressively and achieved successful complete occlusion. We developed this proactive aneurysm-treatment strategy after we followed a patient with MOPD II (Case 7) with a posterior cerebral artery aneurysm that ruptured 4 years later and another patient with MOPD II (Case 9) who suffered an SAH from a newly developed basilar artery aneurysm 2 years after clipping of an ACoA aneurysm, with no other aneurysms identified at the time of initial diagnosis. Additional aneurysms were also identified over the 5 years of subsequent follow-up, and she underwent coiling of the ruptured basilar tip aneurysm, and pipeline-assisted coiling of a VB junction aneurysm and left ICA aneurysm. Five other tiny aneurysms were monitored (2 right MCA aneurysms, 1 left MCA aneurysm, 1 right terminal ICA aneurysm, and 1 right posterior communicating artery aneurysm), but unfortunately, this patient died as a result of a ruptured untreated right-sided aneurysm 5 years after her initial diagnosis.
Because the STA and M 4 arteries in patients with MOPD II are extremely small and fragile, it is not usually possible to perform a direct bypass, although we did so successfully in 1 patient. The indirect encephaloduroar- teriosynangiosis procedures provided robust angiographic revascularization, according to follow-up angiograms, and excellent short-and long-term neurological outcomes. Few successful neurovascular surgical cases of patients with MOPD II have been reported in the literature.
5,10,13 Young et al. 13 and Kannu et al. 5 separately described 1 case each of a child with MOPD II and MMD. Developmental delay was noted in the child studied by Young et al. 13 at 2.5 years, and despite surgical attempts to restore the carotid circulation, the child experienced progressive disability and loss of skills caused by ongoing multiple cerebral infarctions. In the case described by Kannu et al., 5 the child developed sudden right-sided weakness at the age of 2 years, 11 months. Cranial imaging confirmed cerebral infarction secondary to MMD and progressive arterial stenosis; she underwent bilateral encephaloduroarteriosynangiosis and had no additional strokes after surgery. However, her fine and gross motor skills were mildly delayed after the previous cerebral ischemic episodes. Waldron et al. 10 reported 3 cases of patients with MOPD II, multiple intracranial aneurysms, and MMD. Two of the patients (a 15-year-old boy and a 17-year-old girl) presented with aneurysmal SAH, and aneurysm obliteration was performed by either clipping or coiling. One patient had recovered to baseline status by discharge, and 1 died 5 months later of basal ganglia hemorrhage. The third patient was a 22-month-old boy with bilateral MMD who experienced additional strokes despite encephaloduroarteriosynangiosis procedures 6 months earlier. Magnetic resonance imaging revealed new infarcts, and digital subtraction angiography showed bilateral ICA occlusion and patent STA grafts but no revascularization from the onlay grafts. An attempted direct STA-M 2 segment bypass failed to establish adequate cerebral blood flow, and temporalis muscle synangiosis and multiple bur hole placements were eventually performed to encourage hemispheric collateralization. No long-term outcome was reported in these cases.
As shown in our case series, these patients often have multiple other comorbidities. With a mean follow-up of 5.9 years (range 3-10 years), 2 of our 10 patients died of other medical problems. Of those remaining, 1 patient with MMD experienced nondisabling symptoms consistent with TIAs, and another patient who had undergone previous aneurysm clipping experienced an aneurysmal SAH from a newly developed aneurysm. Otherwise, at the time of this writing, the rest of the cohort had an active lifestyle and no new neurological symptoms.
Apart from the technical challenges of surgically managing the intracranial vascular anomalies in this group of patients, anesthesia risks are also an important consideration. Many of these children have severe respiratory problems, such as recurrent upper respiratory tract infection and pneumonia, during the newborn period, and scoliosis can compromise their respiratory capacity. 3 Furthermore, there is increasing evidence that the vascular changes noted intracranially might be part of a more systemic problem, with patients developing coronary artery stenosis, pulmonary artery stenosis, and renal artery aneurysms. 1 Therefore, the involvement of an expert multidisciplinary team is paramount for managing these patients successfully.
Conclusions
To our knowledge, this is the largest reported surgical series of patients with MOPD II and intracranial vascular anomalies. Moyamoya disease presented at a younger age, whereas aneurysms were more prevalent in the older age group. Microneurosurgery with either intracranial revascularization or aneurysm clipping is extremely challenging but feasible at expert centers, and good long-term outcomes are possible. Long-term surveillance with vascular imaging is also extremely important in view of the progressive nature of these intracranial vascular anomalies.
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